ARHGEF18 activators constitute a diverse group of chemical entities that can modulate the activity of ARHGEF18, a guanine nucleotide exchange factor, directly or indirectly. This protein is integral to the regulation of Rho family GTPases, especially RhoA, which plays pivotal roles in various cellular processes like cytoskeletal dynamics, cell motility, and cell adhesion.
The list of compounds associated with the activation of ARHGEF18 includes growth factors like EGF. These factors are known to stimulate cellular pathways, some of which culminate in the activation of Rho GTPases, thereby influencing ARHGEF18 activity. Other chemicals like LPA and Bradykinin can activate signaling intermediaries that can indirectly affect ARHGEF18's function. For instance, LPA is recognized to activate Rho GTPases, while Bradykinin can influence calcium signaling through phospholipase C activation. Similarly, compounds such as Forskolin, which elevate intracellular cAMP levels, can modulate a myriad of signaling cascades that may intersect with pathways involving ARHGEF18. On the other hand, specific inhibitors like U-73122 and NSC 23766, targeting phospholipase C and Rac1 GTPase activation respectively, provide insights into how the interruption of these pathways can impact ARHGEF18's activity. Moreover, ATP, known to act on purinergic receptors, can modulate calcium signaling, and thereby the pathways associated with ARHGEF18.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
Lysophosphatidic acid (LPA) can activate Rho GTPases, which may in turn influence ARHGEF18's activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
By elevating cAMP levels, forskolin can modulate various signaling cascades, possibly affecting the pathways in which ARHGEF18 is involved. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin can activate phospholipase C, potentially affecting inositol trisphosphate (IP3) levels and calcium signaling, which might indirectly influence ARHGEF18. | ||||||
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $38.00 $74.00 | 9 | |
ATP, when released extracellularly, can act on purinergic receptors, potentially influencing calcium signaling and possibly pathways associated with ARHGEF18. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
This Rho-associated protein kinase (ROCK) inhibitor can potentially impact pathways related to ARHGEF18 through its action on the Rho/ROCK signaling axis. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
As a specific inhibitor of Rac1 activation, NSC 23766 can modulate pathways associated with Rho family GTPases, which might influence ARHGEF18's activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate (S1P) can activate Rho GTPases, which may have an indirect influence on ARHGEF18's role in the cell. | ||||||